AA
ZBH icon

AlphaCentric Advisors’s Zimmer Biomet ZBH Stock Holding History

AlphaCentric Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$623K Buy
+5,895
New +$633K 0.62% 46

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

AlphaCentric Advisors's ZBH Position: Q4 2024 in Review

AlphaCentric Advisors opened a new position in Zimmer Biomet (ZBH) in Q4 2024: 5,895 shares worth $623K. The stake represents 0.62% of the portfolio and ranks #46 among its holdings.

1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • AlphaCentric Advisors held 5,895 shares of Zimmer Biomet worth $623K as of Q4 2024.
  • Zimmer Biomet was a new AlphaCentric Advisors position in Q4 2024.
  • Zimmer Biomet made up 0.62% of AlphaCentric Advisors's portfolio in Q4 2024, its #46 holding.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.